Belén Garijo: Uniting around a shared commitment to something greater

Belén Garijo shared a post on LinkedIn:

“Every year, we bring together the top leaders of Merck Group to reflect on our achievements and chart the course for the future.

You might wonder, ‘What makes your leadership summit different?’ For me, it’s the energy that comes from collaborating with this incredible team.

It’s not just about reviewing priorities or identifying challenges—it’s about combining diverse perspectives and uniting around a shared commitment to something greater.

We didn’t just talk about the future this year—we actively shaped it. I’m leaving the summit feeling energized by the teamwork and excited for what’s next as we push the boundaries of innovation and work toward sustainable success.”

Source: Belén Garijo/LinkedIn

Belén Garijo is the Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015.

In July 2020, Belén Garijo was appointed Vice Chairman of the Executive Board and Deputy CEO in addition to her role as CEO of the Healthcare business. She moved from Deputy CEO to CEO in May 2021.

Before joining Merck, Belén Garijo served as the Senior Vice President of Global Operations Europe at Sanofi-Aventis and Global Integration Leader of Genzyme after its acquisition by Sanofi.